Literature DB >> 8588672

Ototoxicity of ear drops: a clinical perspective.

T E Linder1, S Zwicky, P Brändle.   

Abstract

Although experimental data confirm the presence of ototoxicity due to topical ear drops, the clinical relevance still remains debatable. Only few case reports document sensorineural hearing loss (SNHL) attributable to ototopical preparations in patients with chronic otitis media. A careful review of 134 patients charts evaluated between 1953 and 1995 for possible antibiotic related ototoxicity revealed two patients with bilateral profound SNHL attributable to excessive administration of framycetin- and polymyxin-containing ear drops in the presence of tympanic membrane perforation. Although ototopical preparations are widely used, they rarely induce SNHL. The authors emphasize patient education, application of topical ear drops using soaked gauze strips, and documentation of the patients hearing status at the beginning of the treatment regimen.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8588672

Source DB:  PubMed          Journal:  Am J Otol        ISSN: 0192-9763


  6 in total

1.  Quinolone ear drops for chronic otitis media. They are safer and more effective than aminoglycosides.

Authors:  S Ghosh; A Panarese; A J Parker; P D Bull
Journal:  BMJ       Date:  2000-07-15

2.  External Otitis: A Challenge in Management.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-04       Impact factor: 3.725

3.  The use of eardrops in an ENT department.

Authors:  S Natsch; E A Mylanus; J J Mulder; Y A Hekster
Journal:  Pharm World Sci       Date:  1999-12

4.  Sensorineural hearing loss in patients with chronic otitis media.

Authors:  Sady Selaimen da Costa; Letícia Petersen Schmidt Rosito; Cristina Dornelles
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-07-16       Impact factor: 2.503

5.  Clinical Pharmacogenetics Implementation Consortium Guideline for the Use of Aminoglycosides Based on MT-RNR1 Genotype.

Authors:  John Henry McDermott; Joshua Wolf; Keito Hoshitsuki; Rachel Huddart; Kelly E Caudle; Michelle Whirl-Carrillo; Peter S Steyger; Richard J H Smith; Neal Cody; Cristina Rodriguez-Antona; Teri E Klein; William G Newman
Journal:  Clin Pharmacol Ther       Date:  2021-06-20       Impact factor: 6.875

Review 6.  A benefit-risk assessment of ofloxacin otic solution in ear infection.

Authors:  Talen K H Wai; Michael C F Tong
Journal:  Drug Saf       Date:  2003       Impact factor: 5.228

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.